What I do not understand is why the new 336 reexam is of such importance. Unlikely to happen. If it does, it will simply be a buying opportunity, unless you think the examiner is going to come to a different result using the same prior art which the prior examiner says does not do it.

Is not the prospects of the 148 much more important at this point? The liklihood is that it will emerge unamended. That would be huge, IMHO.

If the examiner porceeds with a reexam of the 336, I will be looking to buy additional shares. So, to me it doesn't matter what the examiner does. Either way, I will be happy.

Opty